# Whole Blood Point of Care Metabolic Measurement

> **NIH NIH R44** · SEQUITUR HEALTH CORP. · 2022 · $196,280

## Abstract

Parent Grant: HD107897
PA-21-345 Administrative Supplement for Long-Term Investigator
Project Summary
 Sequitur Health Corp. is performing research for a National Institutes of Health Phase II Small Business
Innovation Research (SBIR) Parent Grant: HD107897 to develop a point of care system for measurement of an
analyte directly from a drop of whole blood. The Sequitur system has >90% accuracy for measurement of this
analyte compared to the U.S. Food and Drug Administration approved clinical laboratory instrument method for
measuring this analyte.
 Sequitur Health Corp. is a women-owned small business that is partially owned by a female from a
socially disadvantaged group, as defined by the United States Small Business Association (U.S. SBA).
Sequitur will use this supplement to hire a Ph.D.-level Hispanic female, who is from a socially disadvantaged
group as defined by the U.S. SBA. This Long-Term Investigator will contribute to the completion of the parent
Phase II SBIR award ongoing research Aims. The immediate impact of this administrative supplement will be
to increase diversity in the United States Small Business workforce. The long-term impact of this administrative
supplement will be to help the individual hired contribute to the ongoing research, develop more skills, and
launch a successful career as an entrepreneurial-minded independent scientist.

## Key facts

- **NIH application ID:** 10618091
- **Project number:** 3R44HD107897-02S1
- **Recipient organization:** SEQUITUR HEALTH CORP.
- **Principal Investigator:** Marylaura Lind Thomas
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $196,280
- **Award type:** 3
- **Project period:** 2021-09-17 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10618091

## Citation

> US National Institutes of Health, RePORTER application 10618091, Whole Blood Point of Care Metabolic Measurement (3R44HD107897-02S1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10618091. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*